EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Clinical Details of MYH9-Related Disease and DFNA17 in a Large Japanese Hearing Loss Cohort

Shinichi Goto iD, Akira Sasaki iD, Shin-Ya Nishio iD, Chikako Shinkawa iD, Kiyoshi Oda, Tetsuro Wada, Kotaro Ishikawa, Tetsuo Ikezono iD, Shin-Ichiro Oka, Nobuhiro Nishiyama, Taku Ito iD, Marina Kobayshi und 9 weitere

Genes · 2026

DOI: 10.3390/genes17020154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2026. Verfasst von Shinichi Goto und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology Head and Neck surgery, Hirosaki University Graduate School of Medicine, Hirosaki 036-8560, Japan. Hauptthemen laut MEDLINE: Myosin Heavy Chains, Hearing Loss, Sensorineural, Thrombocytopenia, Molecular Motor Proteins. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health, Labor and Welfare of Japan, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: MYH9 gene variants cause MYH9-related disease (MYH9-RD), which is also known as Epstein syndrome, Fechtner syndrome, May–Hegglin anomaly, and Sebastian syndrome. MYH9-RD is characterized by sensorineural hearing loss, macrothrombocytopenia, thrombocytopenia, hematuria/proteinuria, glomerulonephritis, cataracts purpura, and mucosal bleeding. In addition, the MYH9 gene is also known to be causative of autosomal dominant non-syndromic hearing loss (DFNA17). MYH9-RD is a relatively rare disorder, and the detailed clinical features and mutational spectra remain unclear.

Methods

In this study, we performed next-generation sequencing analysis for 15,684 hearing loss patients and identified MYH9-associated hearing loss patients. Detailed clinical information was collected for these patients and summarized.

Results

In this study, we identified 24 patients from 18 families with MYH9-associated hearing loss. We clarified the details of hearing deterioration observed in patients based on collected serial audiogram data. Some cases showed rapid hearing deterioration that worsened by about 50 dB within 5 years. Hearing loss is more likely to progress in patients with myosin head domain variants than in patients with myosin tail domain variants, but hearing loss in each set of patients finally deteriorates to bilateral profound hearing loss.

Conclusions

In this study, we were able to clarify the detailed characteristics of MYH9-RD- and DFNA17-related hearing loss in a relatively large number of patients, particularly in some cases that showed rapid and asymmetrical hearing deterioration progressing to bilateral profound hearing loss. Our data will be useful for providing more appropriate treatment and follow-up for MYH9-associated hearing loss.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myosin Heavy ChainsHearing Loss, SensorineuralThrombocytopeniaMolecular Motor ProteinsHumansFemaleMaleAdultJapanMutationMiddle AgedAdolescentChildYoung AdultChild, PreschoolPedigreeEast Asian People

Stichwörter der Autor:innen

DFNA17MYH9MYH9-related diseasecochlear implantationprogressive hearing loss

Substanzen

Myosin Heavy ChainsMYH9 protein, humanMolecular Motor Proteins

Autor:innen und Institutionen

  • Department of Otorhinolaryngology Head and Neck surgery, Hirosaki University Graduate School of Medicine, Hirosaki 036-8560, Japan.
  • Department of Hearing Implant Sciences, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.
  • Department of Otolaryngology, Head and Neck Surgery, Yamagata University Faculty of Medicine, Yamagata 990-9585, Japan.
  • Department of Otorhinolaryngology, Touhoku Rousai Hospital, Sendai 981-0911, Japan.
  • Department of Otolaryngology-Head & Neck Surgery, Institute of Medicine, University of Tsukuba, Tsukuba 300-8575, Japan.
  • Department of Otolaryngology, National Rehabilitation Center for Persons with Disabilities, Tokorozawa 359-8555, Japan.

ORCID-Profile: Shinichi Goto, Akira Sasaki, Shin-Ya Nishio, Chikako Shinkawa, Tetsuo Ikezono, Taku Ito, Kazuma Sugahara, Takeshi Nakamura, Shin-Ichi Usami

Förderung

  • Ministry of Health, Labor and Welfare of Japan
  • Japan Agency for Medical Research and Development

Zitieren

APA

Goto, S., Sasaki, A., Nishio, S. Y., Shinkawa, C., Oda, K., Wada, T., Ishikawa, K., Ikezono, T., Oka, S. I., Nishiyama, N., Ito, T., Kobayshi, M., Kumakawa, K., Sakuma, N., Nakanishi, H., Morimoto, C., Uehara, N., Okazaki, T., Sugahara, K., …, & Usami, S. I. (2026). The Clinical Details of MYH9-Related Disease and DFNA17 in a Large Japanese Hearing Loss Cohort. Genes. https://doi.org/10.3390/genes17020154

Vancouver

Goto S, Sasaki A, Nishio SY, Shinkawa C, Oda K, Wada T, et al. The Clinical Details of MYH9-Related Disease and DFNA17 in a Large Japanese Hearing Loss Cohort. Genes. 2026. doi:10.3390/genes17020154

BibTeX
@article{Goto2026,
  author = {Goto, Shinichi and Sasaki, Akira and Nishio, Shin-Ya and Shinkawa, Chikako and Oda, Kiyoshi and Wada, Tetsuro and Ishikawa, Kotaro and Ikezono, Tetsuo and Oka, Shin-Ichiro and Nishiyama, Nobuhiro and Ito, Taku and Kobayshi, Marina and Kumakawa, Kozo and Sakuma, Naoko and Nakanishi, Hiroshi and Morimoto, Chihiro and Uehara, Natsumi and Okazaki, Testuya and Sugahara, Kazuma and Nakamura, Takeshi and Usami, Shin-Ichi},
  title = {The Clinical Details of MYH9-Related Disease and DFNA17 in a Large Japanese Hearing Loss Cohort},
  journal = {Genes},
  year = {2026},
  doi = {10.3390/genes17020154}
}
Kostenlos starten →